Free Trial

ABVC BioPharma (ABVC) SEC Filings & 10K Form

ABVC BioPharma logo
$0.66
-0.03 (-4.35%)
(As of 11/1/2024 ET)

Recent ABVC BioPharma SEC Filings

DateFilerForm TypeView
10/25/2024
11:21 AM
ABVC BioPharma (Filer)
Form 424B4
10/18/2024
4:23 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:01 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:30 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:30 PM
ABVC BioPharma (Filer)
Form 424B4
08/16/2024
3:30 PM
ABVC BioPharma (Filer)
Form 424B4
08/16/2024
3:31 PM
ABVC BioPharma (Filer)
Form 424B4
08/15/2024
6:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
2:18 PM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
4:15 PM
ABVC BioPharma (Filer)
Form 424B5
08/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
07/26/2024
3:30 PM
ABVC BioPharma (Filer)
Form POS AM
07/23/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
06/25/2024
4:15 PM
ABVC BioPharma (Filer)
Form 8-K/A
06/24/2024
4:15 PM
ABVC BioPharma (Filer)
Form 8-K/A
06/21/2024
4:02 PM
ABVC BioPharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/24/2024
7:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
1:31 PM
ABVC BioPharma (Filer)
Form 424B4
05/15/2024
4:00 PM
ABVC BioPharma (Filer)
Form NT 10-Q
05/15/2024
8:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:27 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
04/25/2024
1:38 PM
ABVC BioPharma (Filer)
Form POS AM
04/19/2024
4:26 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
7:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
1:47 PM
ABVC BioPharma (Filer)
Form 424B4
04/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
03/26/2024
7:35 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
ABVC BioPharma (Filer)
Form DEFA14A
03/22/2024
4:01 PM
ABVC BioPharma (Filer)
Form S-1/A
03/14/2024
11:08 AM
ABVC BioPharma (Filer)
Form DEFA14A
03/14/2024
10:33 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
8:04 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:14 PM
ABVC BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
3:32 PM
ABVC BioPharma (Filer)
Form 8-K/A
02/13/2024
6:59 PM
ABVC BioPharma (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
02/09/2024
4:04 PM
ABVC BioPharma (Filer)
Form S-1/A
02/08/2024
8:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

01/17/2024
4:01 PM
ABVC BioPharma (Filer)
Form 8-K/A
01/17/2024
3:30 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:00 PM
ABVC BioPharma (Filer)
Form DEF 14A
12/15/2023
4:22 PM
ABVC BioPharma (Filer)
Form PRE 14A
11/20/2023
7:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
8:20 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
7:41 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
7:00 AM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ABVC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners